Salaheddine Ali

Salaheddine Ali

Auto-generated profile, based on publicly available information

Salaheddine Ali

Max Planck Institute for Molecular Genetics, Development and Disease Group, Berlin, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2019 in Nature Genetics
Verified
Journal Article
Closed access
ADAlexandra Despang
Alexandra Despang
RSRobert Schöpflin
Robert Schöpflin
MFMartin Franke
Martin Franke
SASalaheddine Ali
Salaheddine Ali
IJIvana Jerković
Ivana Jerković
DIDaniel M. Ibrahim
Daniel M. Ibrahim

16 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
KHKonstantin Helmsauer
Konstantin Helmsauer
M(Maria Stefanova (Valieva)
Maria Stefanova (Valieva)
SASalaheddine Ali
Salaheddine Ali
RGRocío Chamorro González
Rocío Chamorro González
RSRobert Schöpflin
Robert Schöpflin
RKRichard P. Koche
Richard P. Koche
MYCN amplification drives one in six cases of neuroblastoma. The supernumerary gene copies are commonly found on highly rearranged, extrachromosomal circular DNA (ecDNA). The exact amplicon structure has not been described thus far and the functional relevance of its rearrangements is unknown. Here, we analyze the MYCN amplicon structure using short-read and Nanopore sequencing and its chromatin landscape using ChIP-seq, ATAC-seq and Hi-C. This reveals two distinct classes of amplicons which explain the regulatory requirements for MYCN overexpression. The first class always co-amplifies a proximal enhancer driven by the noradrenergic core regulatory circuit (CRC). The second class of MYCN amplicons is characterized by high structural complexity, lacks key local enhancers, and instead contains distal chromosomal fragments harboring CRC-driven enhancers. Thus, ectopic enhancer hijacking can compensate for the loss of local gene regulatory elements and explains a large component of the structural diversity observed in MYCN amplification.

1 December 2020 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
URUta Rössler
Uta Rössler
AHAnna Floriane Hennig
Anna Floriane Hennig
NSNina Stelzer
Nina Stelzer
SBShroddha Bose
Shroddha Bose
JKJohannes Kopp
Johannes Kopp
UKUwe Kornak
Uwe Kornak
Human induced pluripotent stem cells (hiPSCs) hold great potential for modelling human diseases and the development of innovative therapeutic approaches. Here, we report on a novel, simplified differentiation method for forming functional osteoclasts from hiPSCs. The three‐step protocol starts with embryoid body formation, followed by hematopoietic specification, and finally osteoclast differentiation. We observed continuous production of monocyte‐like cells over a period of up to nine weeks, generating sufficient material for several osteoclast differentiations. The analysis of stage‐specific gene and surface marker expression proved mesodermal priming, the presence of monocyte‐like cells, and of terminally differentiated multinucleated osteoclasts, able to form resorption pits and trenches on bone and dentine in vitro. In comparison to peripheral blood mononuclear cell (PBMC)‐derived osteoclasts hiPSC‐derived osteoclasts were larger and contained a higher number of nuclei. Detailed functional studies on the resorption behaviour of hiPSC‐osteoclasts indicated a trend towards forming more trenches than pits and an increase in pseudo‐resorption. We used hiPSCs from an ARO patient (BIHi002‐A, ARO hiPSCs) with compound heterozygous missense mutations p.(G292E) and p.(R403Q) in CLCN7, coding for the Cl‐/H+‐exchanger ClC‐7, for functional investigations. The patient's leading clinical feature was a brain malformation due to defective neuronal migration. Mutant ClC‐7 displayed residual expression and retained lysosomal co‐localization with OSTM1, but only ClC‐7 harboring the mutation p.(R403Q) gave strongly reduced ion currents. An increased autophagic flux in spite of unchanged lysosomal pH was evident in undifferentiated ARO hiPSCs. ARO hiPSC‐derived osteoclasts showed an increased size compared to hiPSCs of healthy donors. They were not able to resorb bone, indicating a loss‐of‐function effect of the mutations. In summary, we developed a highly reproducible, straightforward hiPSC‐osteoclast differentiation protocol. We demonstrated that osteoclasts differentiated from ARO‐hiPSCs can be used as a disease model for ARO and potentially also other osteoclast‐related diseases.

22 March 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
SHSarah Hochmann
Sarah Hochmann
KOKristy Ou
Kristy Ou
RPRodolphe William Poupardin
Rodolphe William Poupardin
MMMichaela Mittermeir
Michaela Mittermeir
MTMartin Textor
Martin Textor
DSDirk Strunk
Dirk Strunk
Multipotent stromal cells are considered attractive sources for cell therapy and tissue engineering. Despite numerous experimental and clinical studies, broad application of stromal cell therapeutics is not yet emerging. A major challenge is the functional diversity of available cell sources. Here, we investigated the regenerative potential of clinically relevant human stromal cells from bone marrow (BMSCs), white adipose tissue, and umbilical cord compared with mature chondrocytes and skin fibroblasts in vitro and in vivo. Although all stromal cell types could express transcription factors related to endochondral ossification, only BMSCs formed cartilage discs in vitro that fully regenerated critical-size femoral defects after transplantation into mice. We identified cell type–specific epigenetic landscapes as the underlying molecular mechanism controlling transcriptional stromal differentiation networks. Binding sites of commonly expressed transcription factors in the enhancer and promoter regions of ossification-related genes, including Runt and bZIP families, were accessible only in BMSCs but not in extraskeletal stromal cells. This suggests an epigenetically predetermined differentiation potential depending on cell origin that allows common transcription factors to trigger distinct organ-specific transcriptional programs, facilitating forward selection of regeneration-competent cell sources. Last, we demonstrate that viable human BMSCs initiated defect healing through the secretion of osteopontin and contributed to transient mineralized bone hard callus formation after transplantation into immunodeficient mice, which was eventually replaced by murine recipient bone during final tissue remodeling.

17 March 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
GCGiulia Cova
Giulia Cova
JGJuliane Glaser
Juliane Glaser
RSRobert Schöpflin
Robert Schöpflin
CPCesar Augusto Prada-Medina
Cesar Augusto Prada-Medina
SASalaheddine Ali
Salaheddine Ali
SMStefan Mundlos
Stefan Mundlos
Split-Hand/Foot Malformation type 3 (SHFM3) is a congenital limb malformation associated with tandem duplications at the LBX1/FGF8 locus. Yet, the disease patho-mechanism remains unsolved. Here we investigate the functional consequences of SHFM3-associated rearrangements on chromatin conformation and gene expression in vivo in transgenic mice. We show that the Lbx1/Fgf8 locus consists of two separate, but interacting, regulatory domains. Re-engineering of a SHFM3-associated duplication and a newly reported inversion in mice results in restructuring of the chromatin architecture. This leads to ectopic activation of the Lbx1 and Btrc genes in the apical ectodermal ridge (AER) in an Fgf8-like pattern induced by AER-specific enhancers of Fgf8. We provide evidence that the SHFM3 phenotype is the result of a combinatorial effect on gene misexpression in the developing limb. Our results reveal insights into the molecular mechanism underlying SHFM3 and provide conceptual framework for how genomic rearrangements can cause gene misexpression and disease.

11 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
UMUirá Souto Melo
Uirá Souto Melo
JJJerome Jatzlau
Jerome Jatzlau
CPCesar A. Prada-Medina
Cesar A. Prada-Medina
EFElisabetta Flex
Elisabetta Flex
SHSunhild Hartmann
Sunhild Hartmann
MSMalte Spielmann
Malte Spielmann
Heterotopic ossification is a disorder caused by abnormal mineralization of soft tissues in which signaling pathways such as BMP, TGFβ and WNT are known key players in driving ectopic bone formation. Identifying novel genes and pathways related to the mineralization process are important steps for future gene therapy in bone disorders. In this study, we detect an inter-chromosomal insertional duplication in a female proband disrupting a topologically associating domain and causing an ultra-rare progressive form of heterotopic ossification. This structural variant lead to enhancer hijacking and misexpression of ARHGAP36 in fibroblasts, validated here by orthogonal in vitro studies. In addition, ARHGAP36 overexpression inhibits TGFβ, and activates hedgehog signaling and genes/proteins related to extracellular matrix production. Our work on the genetic cause of this heterotopic ossification case has revealed that ARHGAP36 plays a role in bone formation and metabolism, outlining first details of this gene contributing to bone-formation and -disease.